Certified by Founder Lodge
Genezen
United States - Genezen
START UP
1 Disclosed Funding Rounds $18,500,000
0 Participating Investments
-
Founded date
2014
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded in Indianapolis in 2014, Genezen is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide— making viral vector production ac
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 03 ,2023 | Unknown | $18,500,000 |
Ampersand Capital Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Theranautilus | $1,200,000 | (Nov 19, 2024)
SuperAnnotate | $36,000,000 | (Nov 19, 2024)
Plantible | $30,000,000 | (Nov 19, 2024)
ANELLO Photonics | Undisclosed Amount | (Nov 19, 2024)
Bluespine | $7,200,000 | (Nov 19, 2024)
